Prurigo Nodularis Pn clinical trials

Explore recruiting prurigo nodularis pn clinical trials.

Recruiting prurigo nodularis pn studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Prurigo Nodularis Pn trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CDX0159-10: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients with Prurigo Nodularis

Spain, Germany, Poland, Croatia

Therapeutic exploratory (Phase II) EU CTIS Study details

A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Prurigo Nodularis

Sweden, Germany, Spain, Denmark, Belgium, Hungary +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of ICP-332 in Participants with Prurigo Nodularis

Belgium, Poland, Germany, France, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

INCB 18424-320: A phase 3, double-blind, randomised, vehicle-controlled, efficacy and safety study of ruxolitinib cream in participants with Prurigo Nodularis. Topical ruxolitinib evaluation in Prurigo Nodularis (TRuE-PN2)

Austria, Poland, Spain, France, Bulgaria, Germany +2 more